At the same time, one cannot forget the possible existence of a conflict of interest as CHADD generates nearly 2/3 of their revenue from the pharmaceutical community and the federal government. Because to medicate or not to medicate is a persisting dilemma for healthcare workers managing the care and treatment of ADHD patients, the mere fact that the pharmaceutical community contributes to CHADD is suspect. Nevertheless, through the disclaimer CHADD includes on the website addressing their lack of authority and advising individuals that any information on the site is not an attempt to render medical advice or recommendations, exponentially bolsters their standing as an authoritative, accurate, and objective source for all things ADHD.
References
Centers for Disease Control and Prevention. (2017, May 1). Home | Attention deficit hyperactivity disorders (ADHD) | NCBDDD | CDC. Retrieved May 3, 2017, from https://www.cdc.gov/ncbddd/adhd/
CHADD. (2003, August). CHADD and CDC Open National Resource Center on AD/HD. Attention, (AUG 2003, 12-13). Retrieved from http://attention@chadd.org/209.126.179.230/
CHADD. (2017). CHADD funding sources. Retrieved from http://www.chadd.org/About-CHADD/CHADD-funding-sources.aspx
Kapoun, J. (2017, February 13). Categories - Evaluating web pages: Questions to consider - LibGuides at Cornell University. Retrieved from